Quick Takeaways
- Weiss Asset Management LP filed SCHEDULE 13D/A for Theravance Biopharma, Inc. Ordinary Share $0.00001 Par Value (TBPH).
- Disclosed ownership: 14%.
- Date of event: 23 Mar 2026.
Weiss Asset Management LP - 23 Mar 2026 SCHEDULE 13D/A Report for Theravance Biopharma, Inc. Ordinary Share $0.00001 Par Value (TBPH)
- Filing Manager
- Weiss Asset Management LP
- Reporting Manager
- Weiss Asset Management LP
- Symbol
- TBPH
- Shares outstanding
- 51,428,000 shares
- Disclosed Ownership
- 7,457,060 shares
- Ownership
- 14%
- Form type
- SCHEDULE 13D/A
- Filing time
- 25 Mar 2026, 16:05:02 UTC
- Date of event
- 23 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Weiss Asset Management LP disclosed 14% ownership in Theravance Biopharma, Inc. Ordinary Share $0.00001 Par Value (TBPH) on 23 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 25 Mar 2026, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Weiss Asset Management LP | 14% | 7,457,060 | 0 | 7,457,060 | Mary Merrigan | MARY MERRIGAN, AUTHORIZED SIGNATORY | 0001357550 |
| BIP GP LLC | 9% | 4,628,074 | 0 | 4,628,074 | Mary Merrigan | MARY MERRIGAN, AUTHORIZED SIGNATORY | 0001298983 |
| WAM GP LLC | 14% | 7,457,060 | 0 | 7,457,060 | Mary Merrigan | MARY MERRIGAN, AUTHORIZED SIGNATORY | 0001504664 |
| Andrew M. Weiss | 14% | 7,457,060 | 0 | 7,457,060 | Mary Merrigan | MARY MERRIGAN, ATTORNEY-IN-FACT FOR ANDREW M. WEISS*** | 0001357643 |